Literature DB >> 22985509

Effects of the active constituents of Crocus Sativus L., crocins, in an animal model of obsessive-compulsive disorder.

G Georgiadou1, P A Tarantilis, N Pitsikas.   

Abstract

Crocins are among the active components of the plant Crocus Sativus L. C. Sativus L. and its constituents were effective in different models of psychiatric disorders including anxiety and depression. Obsessive-compulsive disorder (OCD) is a common psychiatric disorder defined by the presence of obsessive thoughts and repetitive compulsive actions. The non selective serotonin (5-HT) receptor agonist mCPP is known to induce OCD-like behavior (excessive self-grooming) in rodents and exacerbate symptoms in patients with OCD. The present study investigated whether or not crocins were able to counteract excessive self-grooming induced by mCPP (0.6 mg/kg, i.p.) in rats. Crocins (30 and 50mg/kg, i.p.) attenuated mCPP-induced excessive self-grooming. The present results also indicate that these effects of crocins on an animal model of OCD cannot be attributed to changes in locomotor activity. Our findings suggest that the active constituents of C. Sativus L. crocins might play a role in compulsive behavior and support a functional interaction between crocins and the serotonergic system.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22985509     DOI: 10.1016/j.neulet.2012.08.081

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  23 in total

1.  Phytomedicines in the Treatment of Migraine.

Authors:  Thilinie Rajapakse; William Jeptha Davenport
Journal:  CNS Drugs       Date:  2019-05       Impact factor: 5.749

Review 2.  Was Hawan Designed to Fight Anxiety-Scientific Evidences?

Authors:  R K Romana; A Sharma; V Gupta; R Kaur; S Kumar; P Bansal
Journal:  J Relig Health       Date:  2020-02

3.  Effects of saffron on sleep quality in healthy adults with self-reported poor sleep: a randomized, double-blind, placebo-controlled trial.

Authors:  Adrian L Lopresti; Stephen J Smith; Alexandra P Metse; Peter D Drummond
Journal:  J Clin Sleep Med       Date:  2020-06-15       Impact factor: 4.062

Review 4.  A review on the management of migraine in the Avicenna's Canon of Medicine.

Authors:  Arman Zargaran; Afshin Borhani-Haghighi; Pouya Faridi; Saeid Daneshamouz; Abdolali Mohagheghzadeh
Journal:  Neurol Sci       Date:  2016-02-09       Impact factor: 3.307

5.  An examination into the mental and physical effects of a saffron extract (affron®) in recreationally-active adults: A randomized, double-blind, placebo-controlled study.

Authors:  Adrian L Lopresti; Stephen J Smith
Journal:  J Int Soc Sports Nutr       Date:  2022-06-07       Impact factor: 4.948

6.  Crocins, the active constituents of Crocus Sativus L., counteracted ketamine-induced behavioural deficits in rats.

Authors:  Georgia Georgiadou; Vasilios Grivas; Petros A Tarantilis; Nikolaos Pitsikas
Journal:  Psychopharmacology (Berl)       Date:  2013-10-06       Impact factor: 4.530

7.  Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials.

Authors:  Heather Ann Hausenblas; Debbie Saha; Pamela Jean Dubyak; Stephen Douglas Anton
Journal:  J Integr Med       Date:  2013-11

8.  Effects of Saffron Extract on Sleep Quality: A Randomized Double-Blind Controlled Clinical Trial.

Authors:  Barbara D Pachikian; Sylvie Copine; Marlène Suchareau; Louise Deldicque
Journal:  Nutrients       Date:  2021-04-27       Impact factor: 5.717

9.  Distinct behavioral traits and associated brain regions in mouse models for obsessive-compulsive disorder.

Authors:  Xiao Chen; Jihui Yue; Yuchong Luo; Lianyan Huang; Boxing Li; Shenglin Wen
Journal:  Behav Brain Funct       Date:  2021-05-18       Impact factor: 3.759

Review 10.  The Effect of Crocus sativus L. and Its Constituents on Memory: Basic Studies and Clinical Applications.

Authors:  Nikolaos Pitsikas
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-01       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.